Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From models to medicine: advanced preclinical systems and AI enabling RNA therapeutics in triple-negative breast cancer.

European review for medical and pharmacological sciences·2026
Same author

The application of EPSiT in pilonidal sinus disease: an international Delphi consensus study endorsed by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI).

Techniques in coloproctology·2025
Same author

Buccal micronucleus cytome assay to evaluate cyto-genotoxic effects of occupational exposure to antineoplastic drugs: application on a large sample size of workers furnished by an Italian network of oncological hospitals.

Archives of toxicology·2025
Same author

Bioarchaeology aids the cultural understanding of six characters in search of their agency (Tarquinia, ninth-seventh century BC, central Italy).

Scientific reports·2024
Same author

Metal(loid)s and Rare Earth Elements in Posidonia oceanica (L.) Delile (1813) banquettes.

Marine pollution bulletin·2024
Same author

Early change in apparent diffusion coefficient as a predictor of response to neoadjuvant androgen deprivation and external beam radiation therapy for intermediate- to high-risk prostate cancer.

Clinical radiology·2024

Related Experiment Video

Updated: Jul 12, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Cone Beam CT-guided Online Adaptive Radiotherapy for Prostate Stereotactic Body Radiation Therapy.

D M McClatchy1, J Pursley2, C Esposito3

  • 1Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Practical Radiation Oncology
|July 10, 2026
PubMed
Summary

CT-guided online adaptive radiotherapy (CTgART) for prostate SBRT is feasible and reproducible. This method significantly improves target coverage and organ-at-risk sparing in patients undergoing treatment.

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Experiment Videos

Last Updated: Jul 12, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Area of Science:

  • Radiation Oncology
  • Medical Physics

Background:

  • CT-guided online adaptive radiotherapy (CTgART) is an emerging technique for prostate stereotactic body radiotherapy (SBRT).
  • Limited data exists on its feasibility and dosimetric benefits in large, multi-center studies.

Purpose of the Study:

  • To evaluate the feasibility and quantify dosimetric improvements of CTgART for prostate SBRT in a multi-center cohort.
  • To assess the time efficiency and reproducibility of the adaptive planning process.

Main Methods:

  • Retrospective analysis of 74 prostate cancer patients treated with 5-fraction CTgART SBRT across two centers.
  • Collection of adaptive planning timestamps, daily contoured volumes, and dose-volume histogram (DVH) data.
  • Comparison of scheduled vs. adapted plans, analyzing planning time, image shifts, and DVH metrics.

Main Results:

  • Adaptation occurred in 95% of fractions, with 81% of patients receiving 5 adapted fractions. Mean planning time was 18.7 minutes.
  • Daily target volumes remained close to simulation volumes (90% within 5cc).
  • Significant DVH improvements observed in 85% of fractions, notably PTV V100% (52%) and Rectum V15Gy (37%).

Conclusions:

  • CTgART is a timely and reproducible method for prostate SBRT.
  • The technique substantially enhances dosimetric outcomes for both target coverage and organ-at-risk sparing.